Income Statement DaVita Inc.

Equities

DVA

US23918K1088

Healthcare Facilities & Services

Real-time Estimate Cboe BZX Other stock markets 15:55:23 2025-07-18 EDT			5-day change	1st Jan Change
141.05 ^USD	-1.63%		-0.78%	-5.43%

06:23pm	Davita enters seventh amendment to credit agreement	RE
07-17	DaVita Inc. Announces Seventh Amendment Enhances Credit Agreement and Borrowing Capacity	CI

36e00.5CJ1l3wLHB0sfuRENdH7HJ5cDOz87xPRTCumKyc8xkY.nhoj_yZAbylhEI4sQ6OKWPAIfNSxhETgdU7HUV93qDOAUkOiEWhDL1YpsQ

Published financial data: DAVITA INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	11.03B	11.21B	11.18B	11.57B	12.26B
Other Revenues, Total	524M	405M	433M	565M	555M
Total Revenues	11.55B	11.62B	11.61B	12.14B	12.82B
Cost of Goods Sold, Total	7.99B	7.97B	8.21B	8.32B	8.6B
Gross Profit	3.56B	3.65B	3.4B	3.82B	4.22B
Selling General & Admin Expenses, Total	1.21B	1.2B	1.36B	1.47B	1.54B
Depreciation & Amortization - (IS)	630M	681M	733M	745M	724M
Other Operating Expenses, Total	1.84B	1.88B	2.09B	2.22B	2.26B
Operating Income	1.72B	1.77B	1.31B	1.6B	1.95B
Interest Expense, Total	-297M	-280M	-369M	-502M	-529M
Interest And Investment Income	-	-	-	-	-
Net Interest Expenses	-297M	-280M	-369M	-502M	-529M
Income (Loss) On Equity Invest.	26.92M	26.94M	26.52M	27.86M	26.19M
Other Non Operating Income (Expenses)	9.68M	4.64M	16.12M	84.39M	101M
EBT, Excl. Unusual Items	1.46B	1.52B	986M	1.21B	1.55B
Restructuring Charges	-	-	-	-	-
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-	-26.08M	-
Gain (Loss) On Sale Of Investments	-	-3.77M	-20.15M	-	-113M
Gain (Loss) On Sale Of Assets	-16.25M	-	-	-	109M
Asset Writedown	-	-	-	-	-
Legal Settlements	-35M	-	-	-	-
Other Unusual Items	-89.02M	-	-	-7.96M	-19.81M
EBT, Incl. Unusual Items	1.32B	1.52B	966M	1.18B	1.53B
Income Tax Expense	314M	307M	198M	220M	280M
Earnings From Continuing Operations	1B	1.21B	768M	957M	1.25B
Earnings Of Discontinued Operations	-9.65M	-	13.45M	-	-
Net Income to Company	995M	1.21B	782M	957M	1.25B
Minority Interest	-221M	-233M	-221M	-265M	-314M
Net Income - (IS)	774M	978M	560M	692M	936M
Net Income to Common Incl Extra Items	774M	978M	560M	692M	936M
Net Income to Common Excl. Extra Items	783M	978M	547M	692M	936M
Per Share Items
Net EPS - Basic	6.46	9.3	6.03	7.62	11.02
Basic EPS - Continuing Operations	6.54	9.3	5.88	7.62	11.02
Basic Weighted Average Shares Outstanding	120M	105M	92.99M	90.79M	84.99M
Net EPS - Diluted	6.31	8.9	5.85	7.42	10.73
Diluted EPS - Continuing Operations	6.39	8.9	5.71	7.42	10.73
Diluted Weighted Average Shares Outstanding	123M	110M	95.83M	93.18M	87.27M
Normalized Basic EPS	5.76	6.82	4.25	5.41	7.72
Normalized Diluted EPS	5.63	6.53	4.12	5.27	7.52
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	2.35B	2.45B	2.05B	2.35B	2.68B
EBITA	1.73B	1.78B	1.32B	1.61B	1.96B
EBIT	1.72B	1.77B	1.31B	1.6B	1.95B
EBITDAR	3.01B	3.12B	2.72B	3.04B	3.37B
Total Revenues (As Reported)	11.55B	11.62B	11.61B	12.14B	12.82B
Effective Tax Rate - (Ratio)	23.81	20.2	20.5	18.7	18.27
Current Domestic Taxes	68.61M	232M	190M	238M	306M
Current Foreign Taxes	17.48M	14.25M	16.25M	21.01M	31.53M
Total Current Taxes	86.09M	246M	206M	259M	337M
Deferred Domestic Taxes	226M	64.87M	-10.81M	-39.87M	-50.57M
Deferred Foreign Taxes	2.01M	-4.52M	3M	535K	-7.22M
Total Deferred Taxes	228M	60.34M	-7.81M	-39.33M	-57.79M
Normalized Net Income	691M	718M	395M	492M	657M
Interest Capitalized	17.94M	15.28M	12.68M	9.18M	7.98M
Interest on Long-Term Debt	32.36M	29.26M	25.45M	20.9M	18.86M
Supplemental Operating Expense Items
General and Administrative Expenses	1.21B	1.2B	1.36B	1.47B	1.54B
Net Rental Expense, Total	664M	674M	680M	693M	689M
Imputed Operating Lease Interest Expense	150M	137M	174M	247M	255M
Imputed Operating Lease Depreciation	514M	537M	505M	446M	434M
Stock-Based Comp., Other (Total)	91.46M	102M	95.43M	112M	103M
Total Stock-Based Compensation	91.46M	102M	95.43M	112M	103M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	325M	462M	244M	380M	795M
Short Term Investments	20.1M	22.31M	77.69M	11.61M	51.06M
Total Cash And Short Term Investments	345M	484M	322M	392M	846M
Accounts Receivable, Total	1.82B	1.96B	2.13B	2.22B	2.4B
Other Receivables	615M	453M	419M	194M	160M
Total Receivables	2.44B	2.41B	2.55B	2.42B	2.56B
Inventory	112M	107M	109M	143M	135M
Prepaid Expenses	76.39M	72.52M	78.84M	103M	123M
Restricted Cash	177M	93.06M	94.9M	84.57M	84.89M
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	3.15B	3.17B	3.16B	3.14B	3.75B
Gross Property Plant And Equipment	10.87B	11.07B	11.19B	11.33B	11.6B
Accumulated Depreciation	-4.48B	-4.76B	-5.27B	-5.76B	-6.26B
Net Property Plant And Equipment	6.38B	6.3B	5.92B	5.57B	5.33B
Long-term Investments	292M	301M	415M	674M	400M
Goodwill	6.92B	7.05B	7.08B	7.11B	7.38B
Other Intangibles, Total	167M	178M	183M	203M	197M
Deferred Tax Assets Long-Term	-	22.91M	27.71M	34.44M	46.25M
Other Long-Term Assets, Total	76.83M	102M	148M	157M	185M
Total Assets	16.99B	17.12B	16.93B	16.89B	17.29B
Liabilities
Accounts Payable, Total	434M	402M	480M	515M	547M
Accrued Expenses, Total	809M	790M	838M	910M	1B
Current Portion of Long-Term Debt	134M	142M	194M	86.13M	234M
Current Portion of Leases	405M	431M	433M	432M	447M
Current Income Taxes Payable	7.77M	53.79M	18.04M	28.51M	10.3M
Other Current Liabilities	687M	579M	657M	671M	732M
Total Current Liabilities	2.48B	2.4B	2.62B	2.64B	2.97B
Long-Term Debt	7.68B	8.47B	8.46B	8.05B	9B
Long-Term Leases	2.98B	2.93B	2.74B	2.55B	2.39B
Deferred Tax Liability Non Current	810M	831M	783M	726M	665M
Other Non Current Liabilities	150M	119M	105M	183M	170M
Total Liabilities	14.09B	14.75B	14.7B	14.15B	15.19B
Common Stock, Total	110K	97K	90K	89K	90K
Additional Paid In Capital	597M	540M	607M	510M	286M
Retained Earnings	853M	354M	174M	598M	1.53B
Treasury Stock	-	-	-	-	-1.39B
Comprehensive Income and Other	-66.15M	-139M	-69.19M	-52.08M	-311M
Total Common Equity	1.38B	756M	712M	1.06B	121M
Minority Interest	1.51B	1.62B	1.51B	1.69B	1.97B
Total Equity	2.9B	2.37B	2.22B	2.74B	2.09B
Total Liabilities And Equity	16.99B	17.12B	16.93B	16.89B	17.29B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	109M	96.3M	90.4M	87.7M	80M
ECS Total Common Shares Outstanding	110M	97.29M	90.41M	88.82M	80.54M
Book Value / Share	12.59	7.77	7.88	11.89	1.5
Tangible Book Value	-5.7B	-6.47B	-6.55B	-6.26B	-7.45B
Tangible Book Value Per Share	-51.87	-66.49	-72.41	-70.47	-92.52
Total Debt	11.19B	11.98B	11.82B	11.12B	12.07B
Net Debt	10.85B	11.49B	11.5B	10.72B	11.22B
Debt Equivalent Oper. Leases	5.31B	5.39B	5.44B	5.54B	5.51B
Minority Interest, Total (Incl. Fin. Div)	1.51B	1.62B	1.51B	1.69B	1.97B
Equity Method Investments, Total	228M	224M	216M	531M	315M
Account Code - Inventory Valuation	5	5	5	5	5
Land - (BS)	37.92M	34.01M	32.66M	35.22M	50.17M
Buildings, Total	401M	496M	428M	436M	429M
Machinery, Total	3.08B	3.29B	3.76B	4.13B	4.41B
Full Time Employees	67K	69K	70K	70K	76K
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	774M	978M	560M	692M	936M
Depreciation & Amortization - CF	617M	668M	721M	736M	716M
Amortization of Goodwill and Intangible Assets - (CF)	13.81M	12.86M	11.47M	8.97M	7.46M
Depreciation & Amortization, Total	630M	681M	733M	745M	724M
(Gain) Loss From Sale Of Asset	-	-	-	-	-109M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	26.08M	-
(Income) Loss On Equity Investments - (CF)	13.83M	5.22M	8.77M	64.78M	116M
Stock-Based Compensation (CF)	91.46M	102M	95.43M	112M	103M
Tax Benefit from Stock Options	-	-	-	-	-
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	574M	305M	167M	224M	282M
Change In Accounts Receivable	-21.09M	-138M	-148M	172M	-29.77M
Change In Inventories	-12.35M	5.72M	-757K	-32.13M	17.94M
Change In Accounts Payable	37.2M	-30.32M	87.48M	26.89M	1.7M
Change In Income Taxes	-87.39M	36.92M	-24.1M	1.57M	-44.21M
Change in Other Net Operating Assets	-20.54M	-14.82M	85.87M	25.85M	24.52M
Cash from Operations	1.98B	1.93B	1.56B	2.06B	2.02B
Capital Expenditure	-675M	-641M	-603M	-568M	-555M
Sale of Property, Plant, and Equipment	50.14M	61.46M	118M	30.61M	25.86M
Cash Acquisitions	-182M	-187M	-57.31M	-26.39M	-246M
Investment in Marketable and Equity Securities, Total	-18.96M	-16.94M	-86.41M	-208M	4.22M
Other Investing Activities, Total	-	-745K	-782K	-	-
Cash from Investing	-825M	-785M	-630M	-772M	-771M
Long-Term Debt Issued, Total	4.05B	1.62B	2.39B	2.47B	6.62B
Total Debt Issued	4.05B	1.62B	2.39B	2.47B	6.62B
Long-Term Debt Repaid, Total	-4.11B	-861M	-2.4B	-3.02B	-5.52B
Total Debt Repaid	-4.11B	-861M	-2.4B	-3.02B	-5.52B
Issuance of Common Stock	-	-	-	-	20.45M
Repurchase of Common Stock	-1.46B	-1.6B	-840M	-320M	-1.52B
Other Financing Activities, Total	-324M	-239M	-270M	-298M	-427M
Cash from Financing	-1.85B	-1.08B	-1.12B	-1.17B	-817M
Foreign Exchange Rate Adjustments	-13.81M	-10.01M	-29.07M	8.91M	-18.48M
Net Change in Cash	-707M	53.17M	-216M	126M	415M
Supplemental Items
Cash Interest Paid	326M	279M	351M	388M	-
Cash Income Tax Paid (Refund)	155M	210M	344M	268M	388M
Levered Free Cash Flow	749M	1.08B	832M	1.2B	1.18B
Unlevered Free Cash Flow	935M	1.26B	1.06B	1.51B	1.51B
Change In Net Working Capital	187M	-7.19M	-17.8M	-219M	-13.77M
Net Debt Issued / Repaid	-63.53M	754M	-11.28M	-553M	1.11B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	6.26	6.49	4.82	5.92	7.15
Return on Total Capital	7.47	7.78	5.78	7.17	8.72
Return On Equity %	31.4	46.01	33.43	38.52	51.74
Return on Common Equity	44.54	91.48	74.52	78.21	159.08
Margin Analysis
Gross Profit Margin %	30.84	31.38	29.29	31.47	32.91
SG&A Margin	10.5	10.29	11.67	12.14	12
EBITDA Margin %	20.34	21.1	17.62	19.33	20.9
EBITA Margin %	15	15.35	11.4	13.26	15.31
EBIT Margin %	14.88	15.24	11.31	13.19	15.25
Income From Continuing Operations Margin %	8.7	10.43	6.62	7.88	9.76
Net Income Margin %	6.7	8.42	4.83	5.7	7.31
Net Avail. For Common Margin %	6.78	8.42	4.71	5.7	7.31
Normalized Net Income Margin	5.98	6.18	3.4	4.05	5.12
Levered Free Cash Flow Margin	6.49	9.3	7.17	9.85	9.18
Unlevered Free Cash Flow Margin	8.09	10.8	9.15	12.43	11.76
Asset Turnover
Asset Turnover	0.67	0.68	0.68	0.72	0.75
Fixed Assets Turnover	1.82	1.83	1.9	2.11	2.35
Receivables Turnover (Average Receivables)	6.09	5.93	5.47	5.17	5.31
Inventory Turnover (Average Inventory)	76.24	72.79	75.82	65.97	61.93
Short Term Liquidity
Current Ratio	1.27	1.32	1.2	1.19	1.26
Quick Ratio	1.12	1.21	1.1	1.06	1.14
Operating Cash Flow to Current Liabilities	0.8	0.81	0.6	0.78	0.68
Days Sales Outstanding (Average Receivables)	60.08	61.55	66.78	70.61	68.96
Days Outstanding Inventory (Average Inventory)	4.8	5.01	4.81	5.53	5.91
Average Days Payable Outstanding	19.17	19.15	19.6	21.72	22.62
Cash Conversion Cycle (Average Days)	45.71	47.41	51.99	54.42	52.25
Long Term Solvency
Total Debt/Equity	386.43	505.08	531.4	405.21	576.99
Total Debt / Total Capital	79.44	83.47	84.16	80.21	85.23
LT Debt/Equity	367.85	480.89	503.22	386.34	544.41
Long-Term Debt / Total Capital	75.62	79.48	79.7	76.47	80.42
Total Liabilities / Total Assets	82.95	86.15	86.86	83.76	87.9
EBIT / Interest Expense	5.79	6.33	3.56	3.19	3.7
EBITDA / Interest Expense	10.14	11.17	7.39	6.05	6.37
(EBITDA - Capex) / Interest Expense	7.87	8.88	5.75	4.92	5.32
Total Debt / EBITDA	3.71	3.83	4.34	3.66	3.58
Net Debt / EBITDA	3.6	3.68	4.22	3.53	3.33
Total Debt / (EBITDA - Capex)	4.79	4.82	5.57	4.5	4.29
Net Debt / (EBITDA - Capex)	4.64	4.63	5.42	4.34	3.99
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	1.42	0.59	-0.08	4.57	5.56
Gross Profit, 1 Yr. Growth %	2.53	2.37	-6.75	12.35	10.38
EBITDA, 1 Yr. Growth %	-0.9	4.33	-16.56	14.73	14.16
EBITA, 1 Yr. Growth %	-2.09	2.92	-25.75	21.6	21.88
EBIT, 1 Yr. Growth %	-2.08	2.99	-25.86	21.98	22.1
Earnings From Cont. Operations, 1 Yr. Growth %	9.67	20.65	-36.61	24.58	30.7
Net Income, 1 Yr. Growth %	-4.6	26.47	-42.73	23.4	35.4
Normalized Net Income, 1 Yr. Growth %	8.62	4.35	-44.77	24.35	24.17
Diluted EPS Before Extra, 1 Yr. Growth %	39.39	39.28	-35.84	29.95	44.61
Accounts Receivable, 1 Yr. Growth %	1.6	7.31	8.91	-1.55	7.94
Inventory, 1 Yr. Growth %	13.96	-3.76	1.58	31.14	-5.97
Net Property, Plant and Equip., 1 Yr. Growth %	1.29	-1.26	-6.06	-5.87	-4.31
Total Assets, 1 Yr. Growth %	-1.87	0.78	-1.13	-0.2	2.32
Tangible Book Value, 1 Yr. Growth %	19.04	13.44	1.21	-4.39	19.04
Common Equity, 1 Yr. Growth %	-35.15	-45.39	-5.72	48.26	-88.53
Cash From Operations, 1 Yr. Growth %	-20.72	-2.43	-18.97	31.6	-1.8
Capital Expenditures, 1 Yr. Growth %	-12	-4.9	-5.93	-5.87	-2.21
Levered Free Cash Flow, 1 Yr. Growth %	-85.59	44.17	-22.96	43.64	-1.6
Unlevered Free Cash Flow, 1 Yr. Growth %	-82.91	34.25	-15.32	42.02	-0.17
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	0.6	1.01	0.26	2.22	5.06
Gross Profit, 2 Yr. CAGR %	5.23	2.45	-2.3	2.36	11.36
EBITDA, 2 Yr. CAGR %	6.25	1.68	-6	-2.16	14.45
EBITA, 2 Yr. CAGR %	7.25	0.38	-11.69	-4.98	21.74
EBIT, 2 Yr. CAGR %	7.4	0.42	-11.71	-4.91	22.04
Earnings From Cont. Operations, 2 Yr. CAGR %	12.75	15.03	-12.54	-11.13	27.6
Net Income, 2 Yr. CAGR %	120.31	9.84	-14.89	-15.93	29.26
Normalized Net Income, 2 Yr. CAGR %	22.98	6.28	-23.11	-17.13	28.4
Diluted EPS Before Extra, 2 Yr. CAGR %	33.76	39.34	-5.47	-8.69	37.08
Accounts Receivable, 2 Yr. CAGR %	-0.93	4.41	8.11	6.53	3.08
Inventory, 2 Yr. CAGR %	1.96	4.73	-1.13	15.42	11.05
Net Property, Plant and Equip., 2 Yr. CAGR %	37.16	0.01	-3.69	-5.97	-5.1
Total Assets, 2 Yr. CAGR %	-5.71	-0.55	-0.18	-0.67	1.05
Tangible Book Value, 2 Yr. CAGR %	32.31	16.21	7.15	-1.63	6.68
Common Equity, 2 Yr. CAGR %	-38.88	-40.49	-28.25	18.23	-58.76
Cash From Operations, 2 Yr. CAGR %	13.7	-12.05	-11.09	3.27	13.68
Capital Expenditures, 2 Yr. CAGR %	-17.34	-8.52	-5.42	-5.9	-4.06
Levered Free Cash Flow, 2 Yr. CAGR %	20.81	-54.42	6.97	5.2	18.89
Unlevered Free Cash Flow, 2 Yr. CAGR %	7.25	-52.11	7.89	9.66	19.07
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	2	0.6	0.64	1.67	3.32
Gross Profit, 3 Yr. CAGR %	3.17	4.27	-0.71	2.36	4.97
EBITDA, 3 Yr. CAGR %	-0.83	5.6	-4.8	0.46	3
EBITA, 3 Yr. CAGR %	1.7	5.79	-9.22	-1.75	3.24
EBIT, 3 Yr. CAGR %	1.75	5.91	-9.24	-1.67	3.36
Earnings From Cont. Operations, 3 Yr. CAGR %	-2.27	15.32	-5.69	-1.6	1.06
Net Income, 3 Yr. CAGR %	5.25	83.1	-11.59	-3.67	-1.46
Normalized Net Income, 3 Yr. CAGR %	5.44	16.3	-14.65	-9.75	-2.84
Diluted EPS Before Extra, 3 Yr. CAGR %	10.37	35.57	7.59	5.11	6.43
Accounts Receivable, 3 Yr. CAGR %	2.09	1.74	5.89	6.79	7
Inventory, 3 Yr. CAGR %	-15.01	0.01	3.67	8.63	7.79
Net Property, Plant and Equip., 3 Yr. CAGR %	26.57	22.93	-2.06	-4.42	-5.42
Total Assets, 3 Yr. CAGR %	-3.62	-3.6	-0.74	-0.19	0.32
Tangible Book Value, 3 Yr. CAGR %	41	25.69	10.98	3.16	4.83
Common Equity, 3 Yr. CAGR %	-33.43	-41.13	-30.63	-8.61	-45.68
Cash From Operations, 3 Yr. CAGR %	0.22	8.05	-14.42	1.33	1.55
Capital Expenditures, 3 Yr. CAGR %	-9.34	-13.38	-7.67	-5.57	-4.69
Levered Free Cash Flow, 3 Yr. CAGR %	-10.27	28.14	-45.7	18.01	2.88
Unlevered Free Cash Flow, 3 Yr. CAGR %	-10.43	15.59	-42.09	18.24	6.28
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	2.98	1.67	1.3	1.24	2.39
Gross Profit, 5 Yr. CAGR %	2.71	2.24	0.95	3.5	3.95
EBITDA, 5 Yr. CAGR %	0.78	0.27	-3.22	2.43	2.47
EBITA, 5 Yr. CAGR %	1.15	0.82	-4.27	1.34	2.09
EBIT, 5 Yr. CAGR %	1.17	0.84	-4.26	1.45	2.17
Earnings From Cont. Operations, 5 Yr. CAGR %	15.87	0.34	-6.52	3.91	6.43
Net Income, 5 Yr. CAGR %	23.46	2.15	-3.32	34.11	2.92
Normalized Net Income, 5 Yr. CAGR %	2.37	1.58	-7.67	1.49	0.64
Diluted EPS Before Extra, 5 Yr. CAGR %	33.8	11.95	3.74	15.75	18.54
Accounts Receivable, 5 Yr. CAGR %	1.13	5.41	4.45	3.63	5.96
Inventory, 5 Yr. CAGR %	-9.67	-7.71	-9.7	5.91	6.56
Net Property, Plant and Equip., 5 Yr. CAGR %	18.02	17.09	13.47	10.44	-3.28
Total Assets, 5 Yr. CAGR %	-1.71	-1.81	-2.26	-2.44	-0.03
Tangible Book Value, 5 Yr. CAGR %	-1.38	35.03	26.34	13.96	9.24
Common Equity, 5 Yr. CAGR %	-22.25	-30.47	-31.4	-22.19	-43.66
Cash From Operations, 5 Yr. CAGR %	5.26	-0.58	-4.47	6.11	-4.13
Capital Expenditures, 5 Yr. CAGR %	-0.96	-5	-7.79	-10.47	-6.24
Levered Free Cash Flow, 5 Yr. CAGR %	-0.95	-25.33	-4.3	18.42	-25.71
Unlevered Free Cash Flow, 5 Yr. CAGR %	-2.1	-22.18	-3.97	13.18	-22.73